AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2012
Dec 5, 2012
30786_dirs_2012-12-05_943725db-c0ee-4975-ae56-3653f90c521f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2012-12-03
Reporting Person: SCHWARTZ ALICE N (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-03 | Bio-Rad B Common Stock | M | 8000 | $36.00 | Acquired | 489436 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 7608 | $53.50 | Acquired | 497044 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 8227 | $56.40 | Acquired | 505271 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 8413 | $63.00 | Acquired | 513684 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 4000 | $75.00 | Acquired | 517684 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 3000 | $88.48 | Acquired | 520684 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 2000 | $75.38 | Acquired | 522684 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | M | 1000 | $84.57 | Acquired | 523684 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | F | 24014 | $104.85 | Disposed | 499670 | Direct |
| 2012-12-03 | Bio-Rad B Common Stock | G | 720 | — | Disposed | 498950 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $36.00 | M | 8000 | Disposed | 2013-02-05 | Bio-Rad B Common Stock (8000) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $53.50 | M | 7608 | Disposed | 2014-02-04 | Bio-Rad B Common Stock (7608) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $56.40 | M | 8227 | Disposed | 2015-02-09 | Bio-Rad B Common Stock (8227) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $63.00 | M | 8413 | Disposed | 2016-04-03 | Bio-Rad B Common Stock (8413) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $75.00 | M | 4000 | Disposed | 2017-08-01 | Bio-Rad B Common Stock (4000) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $88.48 | M | 3000 | Disposed | 2018-06-11 | Bio-Rad B Common Stock (3000) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $75.38 | M | 2000 | Disposed | 2019-06-10 | Bio-Rad B Common Stock (2000) | Direct |
| 2012-12-03 | Non-Qualified Stock Option (right to buy) | $84.57 | M | 1000 | Disposed | 2020-09-08 | Bio-Rad B Common Stock (1000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 2772912 | Direct |
| Bio-Rad A Common Stock | 34311 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 41176 | Indirect |
Footnotes
F1: The stock option exercise reported is the exercise of derivative securites acquired upon the death of the reporting person's spouse, David Schwartz, former Chairman of the Board of Bio-Rad Laboratories, Inc. and beneficial owner of more than 10% of the Company's Common Stock.
F2: 1,002 unvested restricted stock Class B shares held by the reporting person's late spouse, David Schwartz, were forfeited as of the date of his death, April 1, 2012.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner.
F4: The shares are held by a limited partnership of which the reporting person is a general partner.
F5: The stock option became exercisable in five equal annual installments beginning on February 5, 2004.
F6: The stock option became exercisable in five equal annual installments beginning on February 4, 2005.
F7: The stock option became exercisable in five equal annual installments beginning on February 9, 2006.
F8: The stock option became exercisable in five equal annual installments beginning on April 3, 2007
F9: The stock option became exercisable in five equal annual installments beginning on August 1, 2008.
F10: The stock option became exercisable in five equal annual installments beginning on June 11, 2009.
F11: The stock option became exercisable in five equal annual installments beginning on June 10, 2010.
F12: The stock option became exercisable in five equal annual installments beginning on September 8, 2011.